![](/wp-content/uploads/2022/08/August-5-2022-Blast-Cover.png)
$599
Novo Q2 ’22 London Earnings; Vertex and Amgen Q2 ’22 Earnings Updates
A series of cardiometabolic-related news items have been observed: Novo Nordisk hosted its post-Q2 ’22 earnings (see previous FENIX insight on Q2 ’22 Novo earnings from August 3); Vertex (press release; slides), and Amgen (press release; slides) hosted their Q2 ’22 earnings calls. Below, FENIX provides highlights and insights from the respective news items.